Sethuraman Natarajan Insider Trades

Insider Trading History

Track insider trading activity for Sethuraman Natarajan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.42M 216,317 shares
Last Trade
May 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$399k 25,907 shares
$15.39
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.59M 242,224 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$89.1k 7,577 shares
$11.76
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.64M 249,801 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.5k 3,898 shares
$11.66
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.67M 253,699 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 139,000 shares
$11.93
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.3M 197,899 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.56k 1,760 shares
$5.43
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.31M 199,659 shares
Last Trade
Mar 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$71.7k 6,138 shares
$11.68
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.35M 205,797 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 90,800 shares
$11.94
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $954k 144,997 shares
Last Trade
Dec 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$236k 11,703 shares
$20.15
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.03M 156,700 shares
Last Trade
Dec 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$82.8k 4,088 shares
$20.26
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.06M 160,788 shares
Last Trade
Nov 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2k 100 shares
$20.00
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.06M 160,888 shares
Last Trade
Nov 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.1k 2,700 shares
$20.04
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.08M 163,588 shares
Last Trade
Nov 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.2k 1,409 shares
$20.01
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.1M 167,742 shares
Last Trade
Nov 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$232k 12,299 shares
$18.85
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.17M 177,296 shares
Last Trade
Nov 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$94k 5,171 shares
$18.18
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.2M 182,467 shares
Last Trade
Nov 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.5k 749 shares
$18.02
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
President, Research & Develop.
Holding Value $1.21M 183,216 shares
Last Trade
Oct 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.8k 600 shares
$18.00
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Scientific Officer
Holding Value $1.21M 183,816 shares
Last Trade
Sep 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.9k 2,642 shares
$15.09
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Scientific Officer
Holding Value $1.23M 186,458 shares
Last Trade
Sep 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.14k 600 shares
$15.24
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Scientific Officer
Holding Value $1.23M 187,058 shares
Last Trade
Sep 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.53k 167 shares
$15.13
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Scientific Officer
Holding Value $1.23M 187,225 shares
Last Trade
Sep 04, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.7k 955 shares
$15.42
$6.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up